2025-07-14 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the data you provided.

## Teladoc Health Inc (TDOC) Analysis

Teladoc Health Inc. is a telehealth company providing virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -62.96%
*   **VOO Cumulative Return:** 96.54%
*   **Absolute Deviation:** -159.5
*   **Relative Deviation:** 0.1

**Analysis:** TDOC has significantly underperformed the S&P 500 (VOO) over the period examined. The absolute deviation shows a substantial negative difference in cumulative returns.  The relative deviation indicates that TDOC is near the bottom of its historical performance range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2015-2017  | 76.0%   | 60.6%   | 50.0%    | -0.0   | 5.9    |
| 2016-2018  | 128.0%  | 59.3%   | 110.0%   | -0.0   | 8.4    |
| 2017-2019  | 176.0%  | 59.3%   | 147.0%   | 0.4    | 14.3   |
| 2018-2020  | 237.0%  | 64.0%   | 217.0%   | 0.1    | 34.1   |
| 2019-2021  | -83.0%  | 64.0%   | -132.0%  | 0.1    | 15.6   |
| 2020-2022  | -295.0% | 81.3%   | -297.0%  | 0.0    | 4.0    |
| 2021-2023  | -488.0% | 81.3%   | -506.0%  | -0.6   | 3.7    |
| 2022-2024  | -111.0% | 81.3%   | -137.0%  | -0.8   | 1.6    |
| 2023-2025  | -34.0%  | 72.9%   | -81.0%   | -0.8   | 1.4    |

**Analysis:**

*   **CAGR:**  Historically, Teladoc showed very high growth (CAGR) in earlier periods but has suffered significant negative growth in recent years.
*   **MDD:**  Maximum Drawdown is high, indicating substantial peak-to-trough declines in the investment. This highlights the volatility.
*   **Alpha:**  Alpha measures the excess return relative to a benchmark. The consistently negative alpha values in recent years suggest significant underperformance compared to the market.
*   **Beta:**  Beta measures the stock's volatility relative to the market. Beta values close to 0 or negative suggest the stock has not moved in tandem with the broader market, and in some periods moved inversely.
*   **Cap(B):** Company capitalization (in Billions).

### 2. Recent Price Action

*   **Current Price:** 8.32
*   **Last Market Data:** {'price': 8.085, 'previousClose': 8.32, 'change': -2.82}
*   **5-Day Moving Average:** 8.512
*   **20-Day Moving Average:** 7.921
*   **60-Day Moving Average:** 7.3795

**Analysis:**  The current price is below the 5-day moving average but above the 20-day and 60-day moving averages. This could suggest a short-term downtrend but a potential longer-term upward trend. The  {'price': 8.085, 'previousClose': 8.32, 'change': -2.82} indicates a recent negative change.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 65.37 (Approaching Overbought)
*   **PPO:** 0.52
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34) (Cash Ratio: 0% on 2025-07-07)
*   **Recent (20-day) Relative Deviation Change:** 0.1 (+): Short-term Increase
*   **Expected Return:** -9588.8%

**Analysis:**

*   The MRI suggests a low-risk environment.
*   The RSI is approaching the overbought level (typically above 70), indicating the stock may be overvalued in the short term.
*   The PPO being positive suggests that the short-term moving average is above the long-term moving average, indicating a potential upward trend.
*   The Hybrid Signal suggests caution and recommends buying a limited number of shares, likely due to the MRI and other factors.
*   The recent positive change in relative deviation suggests short-term improvement compared to the benchmark.
*   The extremely negative expected return is alarming and requires further investigation.  It suggests significant concerns about the company's long-term prospects.

### 4. Recent News & Significant Events

*   **2025-07-10:** Business developments, regulatory changes, or market events.
*   **2025-07-14:** Analyst discussions on performance and outlook.
*   **2025-07-11:** Notable volatility due to news, earnings, or executive actions.
*   **2025-07-12:** Risks and opportunities highlighted by market experts.

**Analysis:** Recent news points to volatility and significant events impacting the stock.  It's crucial to research these specific events to understand their impact.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2024-04-26 | -0.49 | 0.65 B$   |
| 2025-05-01 | -0.49 | 0.65 B$   |

**Analysis:**  Teladoc has consistently reported negative EPS, which is a major concern. Revenue has remained relatively stable. The significant loss reported in 2024-08-01 warrants investigation.

### 6. Financial Information

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-03-31 | $0.63B     | 68.73%        |
| 2024-12-31 | $0.64B     | 70.50%        |
| 2024-09-30 | $0.64B     | 71.94%        |
| 2024-06-30 | $0.64B     | 70.73%        |
| 2024-03-31 | $0.65B     | 69.89%        |

| Quarter    | Equity      | ROE       |
|------------|-------------|-----------|
| 2025-03-31 | $1.43B      | -6.52%    |
| 2024-12-31 | $1.49B      | -3.25%    |
| 2024-09-30 | $1.51B      | -2.21%    |
| 2024-06-30 | $1.50B      | -55.77%   |
| 2024-03-31 | $2.29B      | -3.58%    |

**Analysis:**

*   **Revenue:** Revenue has been relatively consistent.
*   **Profit Margin:**  Profit margins appear healthy.
*   **Equity:**  Equity has decreased over the past year, indicating a potential weakening of the company's financial position.
*   **ROE:** Return on Equity is negative, reflecting the company's inability to generate profit from shareholder equity.  The large negative ROE in 2024-06-30 needs explanation.

### 7. Overall Summary

Teladoc Health Inc. (TDOC) presents a mixed picture. While the company shows stable revenue and healthy profit margins, it suffers from consistent negative EPS and ROE, a concerning decrease in equity, and significant underperformance compared to the S&P 500. Recent news suggests volatility and significant events impacting the stock.

**Key Concerns:**

*   **Negative Profitability:** Persistent negative EPS and ROE are major red flags.
*   **Underperformance:** The stock has significantly underperformed the broader market.
*   **High Volatility:** Evidenced by the high Maximum Drawdown.
*   **Extremely Negative Expected Return:**  Suggests serious long-term concerns.
*   **Decreasing Equity:** Signals potential financial weakening.

**Recommendations:**

*   **Further Investigation:**  Thoroughly investigate the reasons behind the negative EPS, ROE, large loss in 2024-08-01 and the extremely negative expected return.
*   **Monitor News:** Closely monitor news and company announcements for any developments that may impact the stock.
*   **Exercise Caution:** Given the current data, a cautious approach is warranted.
